Wall Street News Alert's "stocks to watch" this morning are: Spine Pain Management, Inc. (OTCBB: SPIN), BioForm Medical, Inc. (NASDAQ: BFRM), Amgen, Inc. (NASDAQ: AMGN) and Bank of America Corp. (NYSE: BAC).

Yesterday after the markets closed, Spine Pain Management, Inc. (OTCBB: SPIN) issued a press release providing a corporate overview, as well as its strategic vision through 2011. Based in Houston, Texas, the company delivers solutions to Spinal Health Care Providers for necessary and appropriate treatment for musculo-skeletal / spinal injury (SI) injuries resulting from traumatic accidents, in an order to maximize patient recovery. Utilizing a proven concept that has been developed and successfully deployed over the past 3 1/2 years by its founders, SPIN is now launching an aggressive nationwide "roll out" of Spine Pain Treatment Centers across the U.S. into major metropolitan cities. The initial strategy calls for the development and deployment of a minimum of seven, to as many as ten centers across the U.S. over the next 24 months.

"Based on the recent success of our first clinic in Houston, which generated Third Quarter revenues of $230,000, and net income of $119,642, we anticipate that we should be able to implement our fast-track strategy successfully and efficiently," stated William F. Donovan, M.D., the Company's Chief Executive Officer. "By partnering with prominent Spine and Orthopedic Surgeons and other local Health Care providers in each of our target markets, and streamlining administration such as billing in our Houston office, should allow us to implement our 2 year, nationwide expansion in an efficient and cost-effective manner, while coordinating timely, reasonable, high quality care for SI patients. With all this taken into consideration, SPIN should continue to meet its goals and milestone objectives, while increasing shareholder value in the months and years to come."

Musculoskeletal conditions account for more disability and more costs to the US health care system than any other condition, and with the aging of the population, this burden to society will increase. According to a report in the Journal of the American Medical Association (JAMA), the spending for Spine treatments in the United States totaled nearly $86 billion in 2005, a rise of 65 percent from 1997, after adjusting for inflation. Data from the Agency for Healthcare Research and Quality collected from 23,000 people a year from 1997 to 2005 found that people with spine problems spent about $6,096 each on medical care in 2005, compared to $3,516 in medical spending among those without spine problems. In 2005, American spent an estimated $20 billion on drug treatments for back and neck problems, an increase of 171 percent from 1997. Outpatient treatment for back and neck problems increased 74 percent to about $31 billion during the period. Spending for surgical procedures and other inpatient costs grew by 25 percent to about $24 billion.

The stock closed yesterday at $1.20 a share.

For an in-depth profile of Spine Pain Management, visit http://www.wallstreetnewsalert.com/view-company-profiles.php?profile=SPIN_121509.

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

For more information, please visit www.WallStreetNewsAlert.com and you can also follow Wall Street News Alerts on Twitter at http://twitter.com/wsna.

BioForm Medical, Inc. (NASDAQ: BFRM) up 60.2% on 11.7 million shares traded.

BioForm Medical, Inc. is a medical aesthetics company headquartered in San Mateo, California, developing products that enhance aesthetic procedures performed in dermatology and plastic surgery practices.

Amgen, Inc. (NASDAQ: AMGN) up 2% on 5.2 million shares traded.

Amgen discovers, develops, manufactures and delivers innovative human therapeutics.

Bank of America Corp. (NYSE: BAC) up 4.1% on 180.6 million shares traded.

Bank of America is one of the world's largest financial institutions.

Market Commentary:

The Institute for Supply Management, a trade group of purchasing executives, said its manufacturing index read 55.9 in December after 53.6 in November. A reading above 50 indicates growth.

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're interested in telling your story, we can help. Contact us at info@wallstreetnewsalert.com.

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at http://www.wallstreetnewsalert.com.

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. For current services performed for Spine Pain Management, Inc. (OTCBB: SPIN), WSCF has been compensated Fifty Thousand shares, by a third party who is non-affiliated and may hold a significant position in the stock. WSCF holds all of those shares as of this release, but intends to immediately begin selling its shares as this release is being circulated. WSCF may receive additional compensation for extension of its services. Any additional compensation will be disclosed at such time that WSCF is aware of a client's desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

Contact email: Email Contact URL: http://www.wallstreetnewsalert.com Company: Wall Street News Alert

Bioform Medical (MM) (NASDAQ:BFRM)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024 Plus de graphiques de la Bourse Bioform Medical (MM)
Bioform Medical (MM) (NASDAQ:BFRM)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024 Plus de graphiques de la Bourse Bioform Medical (MM)